Overplay Of Big Data Benefits Worries French Medical Experts
Executive Summary
While big data has a place in drug regulation, it is important to avoid putting too much emphasis on its use in the post-authorization phase, say French medical journal editors in response to the report on big data from EU agency heads and the EMA.